T-Therapeutics I About
T-Therapeutics is a next-generation T cell engager company with a commitment to scientific excellence
Scroll Down
The company was created to harness the power of T cell biology, to create safe and effective treatments for many cancers and autoimmune diseases
We combine deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration.
We are developing optimal TCR based therapeutics using our proprietary OpTiMus® platform which provides an unparalleled source of unique, antigen-specific human TCRs. These TCRs are directed at multiple target classes, many of which have never been worked on before.
T-Therapeutics is developing a pipeline of first-in-class drugs that will become transformative medicines, reshaping the clinical landscape for patients with cancer and autoimmune diseases.
T-Therapeutics I Team
Leadership
T-Therapeutics I Team
Board
T-Therapeutics I Investors
T-Therapeutics I Careers
We are an ambitious organisation with a strong heritage and commitment to world-leading scientific excellence
T-Therapeutics is at the forefront of cutting-edge innovation in the field of T cell receptor-based medicines designed to leverage the power of T cells for therapeutic benefit.
We are an ambitious organisation with a strong heritage and commitment to world-leading scientific excellence. Our employees thrive within an intellectually rich culture of creativity and collaboration, sparking the innovative spirit and creative genius that drive us forward.
Contact
We combine world-leading expertise in biopharmaceuticals, genomics and biology, anchored in a culture of creativity and collaboration
Platform
T-Therapeutics
One Granta
Granta Park
Cambridge
CB21 6DP